Revvity (RVTY) Gains from Investment Securities (2016 - 2026)
Revvity's (RVTY) quarterly Gains from Investment Securities came in at -$99000.0 in Q2 2026, up 84.16% YoY from -$53757.6 in Q2 2025, and up 92.62% on a QoQ basis from -$1.3 million in Q4 2025.
Revvity (RVTY) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Revvity (RVTY) has 11 years of Gains from Investment Securities data on file, last reported at -$99000.0 in Q2 2026.
- Quarterly Gains from Investment Securities rose 84.16% year-over-year to -$99000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$874000.0 (up 89.92% YoY) and the FY2025 annual result came in at -$1.4 million, up 25.09% from the prior year.
- Gains from Investment Securities rose to -$99000.0 in Q2 2026, from -$1.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $6.2 million in Q1 2024 to a low of -$7.9 million in Q4 2024.
- A 5-year average of -$95800.0 and a median of $107000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 553.9% in 2024, down 421.43% in 2024.
- Tracing RVTY's Gains from Investment Securities over 5 years: stood at $693000.0 in 2022, then jumped by 253.54% to $2.4 million in 2023, then plunged by 421.43% to -$7.9 million in 2024, then jumped by 82.97% to -$1.3 million in 2025, then jumped by 92.62% to -$99000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$99000.0 (Q2 2026), -$1.3 million (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 1.63 Mn |
| Jul 5, 2026 | 1.63 Mn |
| Apr 5, 2026 | -99,000.00 |
| Apr 5, 2026 | -99,000.00 |
| Dec 28, 2025 | -1.34 Mn |
| Dec 28, 2025 | -1.34 Mn |
| Sep 28, 2025 | 107,000.00 |
| Sep 28, 2025 | 107,000.00 |
| Jun 29, 2025 | 459,000.00 |
| Jun 29, 2025 | 459,000.00 |
| Mar 30, 2025 | -625,000.00 |
| Mar 30, 2025 | -625,000.00 |
| Dec 29, 2024 | -7.88 Mn |
| Dec 29, 2024 | -7.88 Mn |
| Sep 29, 2024 | -343,000.00 |
| Sep 29, 2024 | -343,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 6.17 Mn |
| Mar 31, 2024 | 6.17 Mn |